Nascent Biotech
Nascent Biotech is building a portfolio of innovative therapeutic antibodies. Learn more
Launch date
Employees
Market cap
AUD11.1m
Enterprise valuation
AUD11m (Public information from Sep 2024)
Share price
$0.04685 NBIO
San Diego California (HQ)
Authorizing premium user...